BioDrugs

Does Parkinson's Disease Have an Immunological Basis?: The Evidence and its Therapeutic Implications
pp. 351-355(5)
Author: Fiszer U.

Gene Therapy for Colorectal Cancer: Therapeutic Potential
pp. 357-367(11)
Authors: Chen M-J.; Chung-Faye G.A.; Searle P.F.; Young L.S.; Kerr D.J.

Immunosuppressive Treatment of Ocular Myasthenia Gravis
pp. 369-378(10)
Authors: Tackenberg B.; Hemmer B.; Oertel W.H.; Sommer N.

New Therapeutic Approaches to the Management of Rheumatoid Arthritis
pp. 379-393(15)
Authors: Hughes L.B.; Moreland L.W.

The Potential of Monoclonal Antibodies to Reduce Reperfusion Injury in Myocardial Infarction
pp. 395-404(10)
Authors: McKenzie M.E.; Gurbel P.A.

Systemic Availability of Inhaled Budesonide and Fluticasone Propionate: Healthy versus Asthmatic Lungs
pp. 405-411(7)
Author: Harrison T.W.

Antibody Responses of Healthy Infants to Concurrent Administration of a Bivalent Haemophilus influenzae Type b-Hepatitis B Vaccine with Diphtheria-Tetanus-Pertussis, Polio and Measles-Mumps-Rubella Vaccines
pp. 413-418(6)
Authors: West D.J.; Rabalais G.P.; Watson B.; Keyserling H.L.; Matthews H.; Hesley T.M.